Non-small cell lung cancer with EGFR mutation
Clinical trials for Non-small cell lung cancer with EGFR mutation explained in plain language.
Never miss a new study
Get alerted when new Non-small cell lung cancer with EGFR mutation trials appear
Sign up with your email to follow new studies for Non-small cell lung cancer with EGFR mutation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new pill shrink tumors in EGFR-Mutant lung cancer?
Disease control Recruiting nowThis trial tests an experimental drug called CFT8919 in people with advanced non-small cell lung cancer that has an EGFR mutation. The goal is to find the safest dose and see whether the drug can shrink tumors. Participants take CFT8919 capsules twice daily and undergo regular ch…
Matched conditions: NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION
Phase 1 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Gut shield: probiotic and amino acid combo may stop cancer drug side effect
Prevention Recruiting nowThis study tests whether adding glutamine and a probiotic (Lactobacillus reuteri) to a bland diet can prevent diarrhea caused by targeted therapy (TKIs) in people with advanced EGFR-mutant non-small cell lung cancer. About 28 participants will either receive the supplemented diet…
Matched conditions: NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION
Phase 3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC